Proactive Investors - Run By Investors For Investors

University of Kansas Medical Center orders another of Polarean’s 9820 Xenon Polariser systems

The hyperpolarised 129-Xenon gas helps to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function
polarean's Xenon Polariser system
25 of Polarean’s polarisers are now either installed or on order

The University of Kansas Medical Center (KUMC) has placed an order for another of Polarean Imaging PLC’s (LON:POLX) 9820 Xenon Polariser system.

KUMC is a major research and teaching hospital and this polariser will form the cornerstone of a new hyperpolarised 129Xe imaging research programme.

WATCH: Polarean on track to complete enrolment for phase III trials

Following receipt of this latest order, Polarean now has a total of 25 polarisers either installed or on order.

“We are delighted to begin our relationship with KUMC and look forward to a long and mutually beneficial work programme which will aim to expand the clinical and public health frontiers of hyperpolarised xenon imaging,” said chief executive Richard Hullihen.

Better MRI scans

MRI scans generally aren’t very useful in assessing lung function, but Polarean is trying to change that. The company has developed a drug-device combination which uses hyperpolarised 129-Xenon gas MRI.

By inhaling and holding a small amount of the gas for just a few seconds, the patient is able to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function.

Polarean, which is looking to sell the gas, the instrument which polarises the gas, and an associated quality assurance device, kicked off a trial of the technology last summer in two sites: Duke University and the University of Virginia and at the University of Cincinnati in June.

The trial is a 'head-to-head' non-inferiority trial testing 129Xe MRI against 133-Xenon (133Xe) scintigraphy.

In morning trading, Polarean shares were 4% higher at 20.80p.

 -- Adds share price --

View full POLX profile View Profile

Polarean Imaging PLC Timeline

Related Articles

abstract technology
February 25 2019
The global provider of technology solutions to the cannabis sector has a footprint in California, but has global intentions
Hundred dollar bills float through air, signalling affluence of Animoca's partnerships
April 23 2019
Animoca Brands is a rapidly growing games company always on the move and seeking new growth opportunities.
Mergers and acquisitions graphic
January 16 2019
Swift’s investors will vote on its planned acquisition of ad specialist Medical Media.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use